<?xml version='1.0' encoding='utf-8'?>
<document id="17323404"><sentence text="Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice."><entity charOffset="22-34" id="DDI-PubMed.17323404.s1.e0" text="itraconazole" /><entity charOffset="39-50" id="DDI-PubMed.17323404.s1.e1" text="fluconazole" /><pair ddi="false" e1="DDI-PubMed.17323404.s1.e0" e2="DDI-PubMed.17323404.s1.e0" /><pair ddi="false" e1="DDI-PubMed.17323404.s1.e0" e2="DDI-PubMed.17323404.s1.e1" /></sentence><sentence text="To determine the prevalence of concomitant use of drugs potentially responsible for interactions among itraconazole and fluconazole users in general practice"><entity charOffset="103-115" id="DDI-PubMed.17323404.s2.e0" text="itraconazole" /><entity charOffset="120-131" id="DDI-PubMed.17323404.s2.e1" text="fluconazole" /><pair ddi="false" e1="DDI-PubMed.17323404.s2.e0" e2="DDI-PubMed.17323404.s2.e0" /><pair ddi="false" e1="DDI-PubMed.17323404.s2.e0" e2="DDI-PubMed.17323404.s2.e1" /></sentence><sentence text="" /><sentence text="During the years 1999-2002, we obtained information from the 'Health Search Database', (HSD) an Italian general practice research database" /><sentence text=" Among a total sample of 457 672 eligible patients, we included those aged &gt;16 years, and whose diagnoses could be classified as mycosis" /><sentence text=" Itraconazole and fluconazole users were then selected"><entity charOffset="1-13" id="DDI-PubMed.17323404.s6.e0" text="Itraconazole" /><entity charOffset="18-29" id="DDI-PubMed.17323404.s6.e1" text="fluconazole" /><pair ddi="false" e1="DDI-PubMed.17323404.s6.e0" e2="DDI-PubMed.17323404.s6.e0" /><pair ddi="false" e1="DDI-PubMed.17323404.s6.e0" e2="DDI-PubMed.17323404.s6.e1" /></sentence><sentence text=" A potentially drug-drug interaction (DDI) occurred when the use of concomitant drugs were recorded within +/-30 days from the date of the first azoles prescription"><entity charOffset="145-151" id="DDI-PubMed.17323404.s7.e0" text="azoles" /></sentence><sentence text=" Interacting drugs were classified according to the summary of product characteristics (SPC) as provided by the Italian Pharmaceutical Repertory (REFI)" /><sentence text="" /><sentence text="From 18 323 cases of mycosis, we selected 4843 itraconazole and 1446 fluconazole users"><entity charOffset="47-59" id="DDI-PubMed.17323404.s10.e0" text="itraconazole" /><entity charOffset="64-80" id="DDI-PubMed.17323404.s10.e1" text="1446 fluconazole" /><pair ddi="false" e1="DDI-PubMed.17323404.s10.e0" e2="DDI-PubMed.17323404.s10.e0" /><pair ddi="false" e1="DDI-PubMed.17323404.s10.e0" e2="DDI-PubMed.17323404.s10.e1" /></sentence><sentence text=" Potentially interacting drugs were prescribed in 8" /><sentence text="7% of itraconazole and 6"><entity charOffset="6-18" id="DDI-PubMed.17323404.s12.e0" text="itraconazole" /></sentence><sentence text="1% of fluconazole users"><entity charOffset="6-17" id="DDI-PubMed.17323404.s13.e0" text="fluconazole" /></sentence><sentence text=" For itraconazole, calcium channel blockers were the most common interacting drugs (3"><entity charOffset="5-17" id="DDI-PubMed.17323404.s14.e0" text="itraconazole" /><entity charOffset="19-26" id="DDI-PubMed.17323404.s14.e1" text="calcium" /><pair ddi="false" e1="DDI-PubMed.17323404.s14.e0" e2="DDI-PubMed.17323404.s14.e0" /><pair ddi="false" e1="DDI-PubMed.17323404.s14.e0" e2="DDI-PubMed.17323404.s14.e1" /></sentence><sentence text="3%), followed by statins (1" /><sentence text="7%) and clarithromycin (1"><entity charOffset="8-22" id="DDI-PubMed.17323404.s16.e0" text="clarithromycin" /></sentence><sentence text="3%), whereas gestoden + ethynylestradiol (2" /><sentence text="5%) and benzodiazepines (1"><entity charOffset="8-23" id="DDI-PubMed.17323404.s18.e0" text="benzodiazepines" /></sentence><sentence text="8%) resulted as the most common interacting drugs among fluconazole users"><entity charOffset="56-67" id="DDI-PubMed.17323404.s19.e0" text="fluconazole" /></sentence><sentence text="" /><sentence text="Data indicate a relevant prevalence of concomitant use of medications potentially leading to drug interactions among azoles users"><entity charOffset="117-123" id="DDI-PubMed.17323404.s21.e0" text="azoles" /></sentence><sentence text=" Because of the wide use of these medications in general practice, they should be used with clinical monitoring in view of their known side effects as well as their potential risk for drug interaction" /><sentence text="" /></document>